JNJ vs MDT
By Alex · Tickerpine
Johnson & Johnson vs Medtronic plc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MDT |
|---|---|---|
| Price | $260.86 | $90.76 |
| Market cap | $628.65B | — |
| P/E ratio | 30.3 | 24.3 |
| ROE | 25.74% | 9.84% |
| Profit margin | 21.48% | 13.20% |
| Revenue growth | 6.60% | 9.90% |
| Dividend yield | 2.05% | 3.18% |
| Beta | 0.23 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MDT in plain English
- MDT is cheaper on earnings (P/E 24.3 vs 30.3).
- JNJ earns a higher return on equity (26% vs 10%).
- MDT is growing revenue faster (10% vs 7%).
- MDT has the higher dividend yield (3.18% vs 2.05%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.